Amy Wesa - Concepedia

Author

Amy Wesa

University of Pittsburgh ORCID

Also Known As

A K Wesa, A. Wesa, Amy K Wesa, Amy K. Wesa, Amy Wesa, Wesa, Amy

101

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

University of Pittsburgh UPMC Hillman Cancer Center Wayne State University The Barbara Ann Karmanos Cancer Institute Celsense (United States)

About

Amy Wesa is an author at University of Pittsburgh specializing in immunology, medicine, and autoimmunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	392
2	Immunology	8	8	392
3	Cell Biology	7	7	371
4	Allergy	3	3	141
5	Pathology	2	2	58

Amy Wesa

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
α-Type-1 Polarized Dendritic Cells Robbie B. Mailliard, Anna Wańkowicz-Kalińska, Quan-Ying Cai, Cancer Research	2004	464
IL-1β induces dendritic cells to produce IL-12 Amy Wesa, Anne Galy International Immunology	2001	124
Dendritic Cells Generated Either from CD34+ Progenitor Cells or from Monocytes Differ in Their Ability to Activate Antigen-Specific CD8+ T Cells Guido Ferlazzo, Amy Wesa, Wei‐Zen Wei, The Journal of Immunology Cd34+ Progenitor CellsMature DcT-regulatory CellImmunologyImmunologic Mechanism	1999	104
A novel probe for the non-invasive detection of tumor-associated inflammation Anthony Balducci, Yi Wen, Yang Zhang, OncoImmunology	2013	103
Polarized Type-1 Dendritic Cells (DC1) Producing High Levels of IL-12 Family Members Rescue Patient TH1-type Antimelanoma CD4+ T cell Responses In Vitro Amy Wesa, Paweł Kaliński, John M. Kirkwood, Journal of Immunotherapy Th1 ResponsesTumor ImmunologyCancer ImmunosurveillanceAutoimmune DiseaseType-1 Dendritic Cells	2006	86
Increased production of pro-inflammatory cytokines and enhanced T cell responses after activation of human dendritic cells with IL-1 and CD40 ligand Amy Wesa, Anne Galy BMC Immunology	2002	81
Effect of Renal Cell Carcinomas on the Development of Type 1 T-Cell Responses Patricia Rayman, Amy Wesa, Amy L. Richmond, Clinical Cancer Research	2004	75
GPL, a Novel Cytokine Receptor Related to GP130 and Leukemia Inhibitory Factor Receptor Caroline Diveu, Eric Lelièvre, David Perret, Journal of Biological Chemistry	2003	73
Preferential Expression of Very Late Antigen-4 on Type 1 CTL Cells Plays a Critical Role in Trafficking into Central Nervous System Tumors Kotaro Sasaki, Xinmei Zhu, Cecilia A. Vasquez, Cancer Research	2007	71
4-1BB-ligand is regulated on human dendritic cells and induces the production of IL-12 Diego J. Laderach, Amy Wesa, Anne Galy Cellular Immunology InflammationCytokineHuman Dendritic CellsAutoimmune DiseaseImmunology	2003	66

Page 1